최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecular pharmaceutics, v.10 no.7, 2013년, pp.2517 - 2527
Choi, Hoo-Kyun (BK21 Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, South Korea) , Cho, Kyoung Bin (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, South Korea) , Phuong, Nguyen Thi Thuy (BK21 Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, South Korea) , Han, Chang Yeob (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, South Korea) , Han, Hyo-Kyung (College of Pharmacy, Dongguk University, Goyang, Gyeonggi-do 410-820, South Korea) , Hien, Tran Thi (BK21 Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, South Korea) , Choi, Hong Seok (BK21 Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, South Korea) , Kang, Keon Wook (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, South Korea)
Our previous studies have shown that multidrug resistance protein 2 (MRP2) is overexpressed in tamoxifen-resistant MCF-7 breast cancer cells (TAMR-MCF-7 cells) and forkhead box-containing protein, O subfamily1 (FoxO1), functions as a key regulator of multidrug resistance 1 (MDR1) gene transcription....
Curr. Med. Chem. Pérez-Tomás R. 1859 13 2006 10.2174/092986706777585077
Drug Resist. Updat. Sparreboom A. 71 6 2003 10.1016/S1368-7646(03)00005-0
Biochem. Pharmacol. Labialle S. 943 64 2002 10.1016/S0006-2952(02)01156-5
Lancet Rose C. 16 1 1985 10.1016/S0140-6736(85)90966-3
Cancer Treat. Rev. Clemons M. 165 28 2002 10.1016/S0305-7372(02)00036-1
Endocr. Relat. Cancer Choi H. K. 293 14 2007 10.1677/ERC-06-0016
Oncogene Greer E. L. 7410 24 2005 10.1038/sj.onc.1209086
Trends. Endocrinol. Metab. Barthel A. 183 16 2005 10.1016/j.tem.2005.03.010
Cell Cycle Vogt P. K. 908 4 2005 10.4161/cc.4.7.1796
Gene Expr. Patterns Hoekman M. F. 134 6 2006 10.1016/j.modgep.2005.07.003
Cell Accili D. 421 117 2004 10.1016/S0092-8674(04)00452-0
Exp. Gerontol. Arden K. C. 709 41 2006 10.1016/j.exger.2006.05.015
Carcinogenesis Han C. Y. 1837 29 2008 10.1093/carcin/bgn092
J. Biol. Chem. Borra M. T. 17187 280 2005 10.1074/jbc.M501250200
Cell Motta M. C. 551 116 2004 10.1016/S0092-8674(04)00126-6
Mech. Ageing Dev. de Boer V. C. 618 127 2006 10.1016/j.mad.2006.02.007
EMBO J. Yeung F. 2369 23 2004 10.1038/sj.emboj.7600244
Biotechnol. J. Stünkel W. 1360 2 2007 10.1002/biot.200700087
Mol. Pharmacol. Lee J. Y. 1082 72 2007 10.1124/mol.107.038174
Hepatology Tanaka T. 1507 30 1999 10.1002/hep.510300617
Mol. Cell. Biol. Kodama S. 7931 24 2004 10.1128/MCB.24.18.7931-7940.2004
Cell. Signal. Asada S. 519 19 2007 10.1016/j.cellsig.2006.08.015
J. Biol. Chem. Frescas D. 20589 280 2005 10.1074/jbc.M412357200
EMBO J. Rena G. 2263 21 2002 10.1093/emboj/21.9.2263
Mol. Pharmacol. Oh W. K. 855 78 2010 10.1124/mol.110.065961
Clin. Cancer Res. Lagas J. S. 6125 12 2006 10.1158/1078-0432.CCR-06-1352
J. Clin. Invest. Evers R. 1310 101 1998 10.1172/JCI119886
Cancer Sci. Kim M. R. 1834 100 2009 10.1111/j.1349-7006.2009.01260.x
Int. J. Cancer Hiscox S. 290 118 2006 10.1002/ijc.21355
Biol. Pharm. Bull. Liu F. 2279 30 2007 10.1248/bpb.30.2279
Pharmacogenomics Sharom F. J. 105 9 2008 10.2217/14622416.9.1.105
Int. J. Cancer Huisman M. T. 824 116 2005 10.1002/ijc.21013
Biochem. Pharmacol. van Zanden J. J. 1657 69 2005 10.1016/j.bcp.2005.03.001
Hepatology Hisaeda K. 1574 39 2004 10.1002/hep.20216
Biochem. Biophys. Res. Commun. Gan L. 1092 337 2005 10.1016/j.bbrc.2005.09.169
Mol. Endocrinol. Perrot V. 2283 19 2005 10.1210/me.2004-0292
Int. J. Mol. Med. Kobayashi Y. 237 16 2005
Cancer Sci. Shiota M. 1177 101 2010 10.1111/j.1349-7006.2010.01503.x
J. Pharmacol. Sci. Fukunaga K. 205 98 2005 10.1254/jphs.FMJ05001X3
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.